Questionnaire data

Islets of Langerhans | Rabbit | Russia

1. Contact address(Person who provides information. This information will be treated confidentially)?

Title: Mr.

First Name: I.E

Last Name: Volkov


State: Moscow

Country: Russia

Institution: Institute of Transplantology and Artificial Organs, Ministry of Health



2. What is the source of your information about human xenotransplantation practices?

3. What is the therapeutic purpose of this xenotransplantation treatment?


4. Where and when is this human xenotransplantation practice taking place?

Country: Russia

Timing: Not available

5. Is this treatment part of a clinical trial?


6. How many patients are included in this clinical trial?

26 children

7. What are the inclusion criteria for patient selection?

i. Duration on the waiting list? Unknown

ii. Life-threatening diseases without alternative therapy? No

iii. Is a protocol available? No

8. What is the animal source of the xenotransplantation product?


9.Source Animals
Do you have information about source animals?


10. Testing of safety
Do you have information about testing of safety?


11. What type of cells/tissues/organs was transplanted?

Cells: Islets of Langerhans




12.What type of exposure to xenogeneic cells was involved?

  • Solid-organ Xenotransplantation: No
  • Cellular Xenotransplantation: Yes
  • Tissue Xenotransplantation: No
  • Human cells exposed to xenogeneic Feeder cells: No
  • Extracorporeal perfusion: No
  • Encapsulation: No
  • Other bioartificial isolation device:
  • Others:

13. Transplant
Do you have information about transplant recipients?


How are the transplant recipients being monitored for infections?    
Which microbial agents have been tested in transplant recipients?     Unknown

Has this microbiological testing been done by a registered laboratory?     
if yes, which?
if not, by whom?

What testing methods were used?
What samples are taken and how often?
For how long will they be store?    
How often is the patient seen for follow-up       
How long are the patients followed?            6- 12 Months
Location of the clinical follow-up examination?
In the same clinic?
if yes, which?
Children Clinical Hospital
if not, where?

14. Have results been presented at a scientific congress?


if yes, where?

15. Have results been published in a scientific journal?


if yes, Where?

16. Is this human clinical trial performed with governmental and/or institutional oversight and supervision?


17. Comment